ACE2 and triple-A syndrome: Twenty-eight days of intramuscular DIZE (30mg/kg) led to significant increases in kidney ACE2 mRNA and ACE2 activity (measured by conversion of Ang II to Ang 1–7) in wild-type mice, and reduced the incidence and severity of Ang II-induced AAA.